Nelson, J., Roe, K., Orillo, B., Shi, P., & Verma, S. (2015). Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection. Antiviral Res.

Nelson, Jacob, Kelsey Roe, Beverly Orillo, Pei-Yong Shi, and Saguna Verma. "Combined Treatment of Adenosine Nucleoside Inhibitor NITD008 and Histone Deacetylase Inhibitor Vorinostat Represents an Immunotherapy Strategy to Ameliorate West Nile Virus Infection." Antiviral Res 2015.

Nelson, Jacob, et al. "Combined Treatment of Adenosine Nucleoside Inhibitor NITD008 and Histone Deacetylase Inhibitor Vorinostat Represents an Immunotherapy Strategy to Ameliorate West Nile Virus Infection." Antiviral Res 2015.